Dan Lin
Impact in
- Health Informatics top 10%
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
- Oncology 8
- Cancer Cells and Metastasis 6
- Cancer-related Molecular Pathways 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Hongyuan Li (4 shared papers)Hongzhong Li (4 shared papers)Jingyuan Wan (4 shared papers)Xiang Zhang (3 shared papers)Rong Jiang (3 shared papers)Bingjie Li (5 shared papers)Jingsi Dong (5 shared papers)Xia Gong (3 shared papers)
- Journals
- Oncology Reports (3 papers)Pharmacology (2 papers)Frontiers in Oncology (2 papers)Frontiers in Pharmacology (2 papers)Chromatographia (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Dan Lin
14 papers receiving 582 citations
Peers
Comparison fields: 5 of 91
- Health Informatics 17
- Biochemistry 69
- Cancer Research 121
- Applied Microbiology and Biotechnology 15
- Pharmacology 104
Countries citing papers authored by Dan Lin
This map shows the geographic impact of Dan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lin more than expected).
Fields of papers citing papers by Dan Lin
This network shows the impact of papers produced by Dan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lin. The network helps show where Dan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 149 | |
| 2 | 2016 | 99 | |
| 3 | 2019 | 83 | |
| 4 | 2018 | 64 | |
| 5 | 2017 | 42 | |
| 6 | 2019 | 35 | |
| 7 | 2019 | 28 | |
| 8 | 2020 | 24 | |
| 9 | 2015 | 19 | |
| 10 | 2019 | 13 | |
| 11 | 2015 | 11 | |
| 12 | 2010 | 9 | |
| 13 | 2010 | 7 | |
| 14 | 2015 | 6 | |
| 15 | 2009 | 0 | |
| 16 | 2013 | 0 | |
| 17 | 2022 | 0 |
About Dan Lin
Dan Lin is a scholar working on Oncology, Pharmacology, Cancer Research, Pulmonary and Respiratory Medicine and Analytical Chemistry, having authored 17 papers that have together received 589 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Analytical Methods in Pharmaceuticals (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Artificial Intelligence in Healthcare and Education (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Health Informatics (17 citations), Biochemistry (69 citations), Cancer Research (121 citations), Applied Microbiology and Biotechnology (15 citations) and Pharmacology (104 citations). Dan Lin has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Hongyuan Li, Hongzhong Li, Jingyuan Wan, Xiang Zhang, Rong Jiang, Bingjie Li, Jingsi Dong, Xia Gong, Ge Kuang and Depei Huang. Their work appears in journals such as Oncology Reports, Pharmacology, Frontiers in Oncology, Frontiers in Pharmacology and Chromatographia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.